COST-EFFECTIVENESS OF ALENDRONATE THERAPY FORCORTICOSTEROID-INDUCED OSTEOPOROSIS IN POSTMENOPAUSAL WOMEN WITH RHEUMATOID ARTHRITIS IN JAPAN

被引：0
|
作者：
Moriwaki, K. [1 ]
Noto, S. [1 ]
Inoue, H. [1 ]
Yanagisawa, S. [2 ]
机构：
[1] Niigata Univ Hlth & Welf, Niigata, Japan
[2] Himeji Dokkyo Univ, Fac Pharmaceut Sci, Himeji, Hyogo, Japan
来源：
VALUE IN HEALTH | 2012年 / 15卷 / 07期
关键词：
D O I：
10.1016/j.jval.2012.08.1399
中图分类号：
F [经济];
学科分类号：
02 ;
摘要：
引用
收藏
页码：A447 / A447
页数：1
相关论文
共 50 条
  • [1] COST-EFFECTIVENESS OF ALENDRONATE THERAPY FOR OSTEOPENIC POSTMENOPAUSAL WOMEN IN JAPAN
    Moriwaki, K.
    Komaba, H.
    Noto, S.
    Yanagisawa, S.
    Inoue, H.
    Takeshi, T.
    Fukagawa, M.
    Takahashi, H. E.
    [J]. VALUE IN HEALTH, 2012, 15 (04) : A46 - A47
  • [2] Cost-effectiveness of alendronate therapy for osteopenic postmenopausal women
    Schousboe, JT
    Nyman, JA
    Kane, RL
    Ensrud, KE
    [J]. ANNALS OF INTERNAL MEDICINE, 2005, 142 (09) : 734 - 741
  • [3] Cost-Effectiveness of Alendronate for the Treatment of Osteopenic Postmenopausal Women in Japan
    Moriwaki, Kensuke
    Komaba, Hirotaka
    Noto, Shinichi
    Yanagisawa, Shinichiro
    Takiguchi, Toru
    Inoue, Hiroki
    Toujo, Takeshi
    Fukagawa, Masafumi
    Takahashi, Hideaki E.
    [J]. JOURNAL OF BONE AND MINERAL RESEARCH, 2013, 28 (02) : 395 - 403
  • [4] The cost-effectiveness of therapy with Teriparatide and alendronate in women with severe osteoporosis
    Liu, Hau
    Michaud, Kaleb
    Nayak, Smita
    Karpf, David B.
    Owens, Douglas K.
    Garber, Alan M.
    [J]. ARCHIVES OF INTERNAL MEDICINE, 2006, 166 (11) : 1209 - 1217
  • [5] Cost-effectiveness of alendronate in the treatment of postmenopausal women in the UK
    Borgström, F
    Johnell, O
    Jönsson, B
    Kanis, J
    Kong, SX
    Sen, SS
    [J]. OSTEOPOROSIS INTERNATIONAL, 2003, 14 : S13 - S13
  • [6] Should postmenopausal women with rheumatoid arthritis who are starting corticosteroid treatment be screened for osteoporosis? A cost-effectiveness analysis
    Solomon, DH
    Kuntz, KM
    [J]. ARTHRITIS AND RHEUMATISM, 2000, 43 (09): : 1967 - 1975
  • [7] The cost-effectiveness of alendronate in the management of osteoporosis
    Kanis, John A.
    Adams, Judith
    Borgstrom, Fred
    Cooper, Cyrus
    Jonsson, Bengt
    Preedy, Danielle
    Selby, Peter
    Compston, Juliet
    [J]. BONE, 2008, 42 (01) : 4 - 15
  • [8] COST-EFFECTIVENESS OF ABALOPARATIDE FOR THE TREATMENT OF POSTMENOPAUSAL WOMEN WITH OSTEOPOROSIS
    Hiligsmann, M.
    Williams, S. A.
    Fitzpatrick, L. A.
    Reginster, J. -Y.
    [J]. OSTEOPOROSIS INTERNATIONAL, 2018, 29 : S50 - S51
  • [9] COST-EFFECTIVENESS OF ABALOPARATIDE FOR THE TREATMENT OF POSTMENOPAUSAL WOMEN WITH OSTEOPOROSIS
    Hansson-Hedblom, A.
    Geale, K.
    Borgstrom, F.
    Johansson, H.
    Fitzpatrick, L.
    Kanis, J. A.
    [J]. VALUE IN HEALTH, 2018, 21 : S197 - S197
  • [10] The cost-effectiveness of osteoporosis screening strategies for postmenopausal women
    Nayak, S.
    Greenspan, S. L.
    Liu, H.
    Michaud, K.
    Owens, D. K.
    Roberts, M. S.
    [J]. JOURNAL OF GENERAL INTERNAL MEDICINE, 2008, 23 : 410 - 411
12345